Search

Your search keyword '"Ficker, Joachim H."' showing total 329 results

Search Constraints

Start Over You searched for: Author "Ficker, Joachim H." Remove constraint Author: "Ficker, Joachim H."
329 results on '"Ficker, Joachim H."'

Search Results

3. Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

6. Prävalenz und Prädiktoren der positiven Atemwegsdrucktherapie bei obstruktiver Schlafapnoe: eine bevölkerungsrepräsentative Studie

7. CAT score single item analysis in patients with COPD: Results from COSYCONET

10. Assessment of clinical outcome after endoscopic lung volume reduction with one-way valves in emphysema patients and a very-low 6 minute walk test at baseline

11. Bronchoscopic Thermal Vapor Ablation (BTVA) in patients with severe upper lobe predominant emphysema: 36 months follow-up results from a prospective registry

17. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

18. German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM)

21. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial

22. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment

24. Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study

26. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

29. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis

33. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET

34. Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET

35. Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV

36. Erratum to: German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM)

37. sj-pdf-1-tam-10.1177_17588359211012361 – Supplemental material for Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

42. Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

43. Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

46. Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET

47. an international multicentre single-arm clinical trial

48. Arousals: Aktueller Stand, Klinische Bedeutung und offene Fragen

50. Survival and quality of life after early discharge in low-risk pulmonary embolism

Catalog

Books, media, physical & digital resources